Metro Atlanta's MiMedx to spin out subsidiary to focus on biopharma

Marietta-based MiMedx Group, Inc. (NASDAQ: MDXG) has signed an agreement to divest the company's subsidiary, Stability Biologics LLC, back to its original stockholders. MiMedx's said its transition into a biopharmaceutical company was an impetus for this divestiture initiative. MiMedx Group is developing and marketing regenerative and therapeutic biologics with human placental tissue allografts and patent-protected processes for multiple sectors of health care. In January of 2016, the company acquired…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news